Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Finished Goods (2021 - 2026)

Organogenesis Holdings has reported Finished Goods over the past 5 years, most recently at $14.0 million for Q4 2025.

  • For Q4 2025, Finished Goods rose 16.43% year-over-year to $14.0 million; the TTM value through Dec 2025 reached $14.0 million, up 16.43%, while the annual FY2025 figure was $14.0 million, 16.43% up from the prior year.
  • Finished Goods for Q4 2025 was $14.0 million at Organogenesis Holdings, down from $24.4 million in the prior quarter.
  • Over five years, Finished Goods peaked at $24.4 million in Q3 2025 and troughed at $10.4 million in Q2 2023.
  • A 5-year average of $13.9 million and a median of $12.8 million in 2023 define the central range for Finished Goods.
  • Biggest five-year swings in Finished Goods: dropped 23.51% in 2022 and later soared 87.48% in 2025.
  • Year by year, Finished Goods stood at $15.0 million in 2021, then dropped by 23.51% to $11.5 million in 2022, then rose by 25.93% to $14.5 million in 2023, then dropped by 16.68% to $12.0 million in 2024, then grew by 16.43% to $14.0 million in 2025.
  • Business Quant data shows Finished Goods for ORGO at $14.0 million in Q4 2025, $24.4 million in Q3 2025, and $18.3 million in Q2 2025.